Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $3.911B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 2,965,160 | $555M | 14.2% | — | — | COM | 76155X100 |
| KYMR | KYMERA THERAPEUTICS INC | 3,872,052 | $444M | 11.4% | — | — | COM | 501575104 |
| XOMA | XOMA ROYALTY CORPORATION | 7,593,303 | $323M | 8.3% | — | — | COM NEW | 98419J206 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 16,001,284 | $312M | 8.0% | — | — | CLASS A ORD | 61559X104 |
| GHRS | GH RESEARCH PLC | 8,650,158 | $233M | 5.9% | — | — | ORDINARY SHARES | G3855L106 |
| GPCR | STRUCTURE THERAPEUTICS INC | 3,366,823 | $181M | 4.6% | — | — | SPONSORED ADS | 86366E106 |
| NKTR | NEKTAR THERAPEUTICS | 2,391,075 | $167M | 4.3% | — | — | COM NEW | 640268306 |
| MIRM | MIRUM PHARMACEUTICALS INC | 1,056,027 | $124M | 3.2% | — | — | COM | 604749101 |
| XNCR | XENCOR INC | 7,133,720 | $115M | 2.9% | — | — | COM | 98401F105 |
| ALKS | ALKERMES PLC | 2,154,704 | $113M | 2.9% | — | — | SHS | G01767105 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 4,460,886 | $108M | 2.8% | — | — | COM | 61225M102 |
| CGEM | CULLINAN THERAPEUTICS INC | 5,750,683 | $105M | 2.7% | — | — | COM | 230031106 |
| PVLA | PALVELLA THERAPEUTICS INC NE | 672,789 | $103M | 2.6% | — | — | COM | 697947109 |
| ZYME | ZYMEWORKS INC | 3,649,142 | $95.39M | 2.4% | — | — | COM | 98985Y108 |
| KURA | KURA ONCOLOGY INC | 8,445,769 | $92.65M | 2.4% | — | — | COM | 50127T109 |
| IRON | DISC MEDICINE INC | 1,153,612 | $84.38M | 2.2% | — | — | COM | 254604101 |
| STOK | STOKE THERAPEUTICS INC | 2,547,557 | $83.36M | 2.1% | — | — | COM | 86150R107 |
| OLMA | OLEMA PHARMACEUTICALS INC | 5,295,893 | $66.25M | 1.7% | — | — | COM | 68062P106 |
| ANNX | ANNEXON INC | 8,698,173 | $49.67M | 1.3% | — | — | COM | 03589W102 |
| CBIO | CRESCENT BIOPHARMA INC. | 2,748,763 | $49.48M | 1.3% | — | — | COM | G2545C104 |
| ACIU | AC IMMUNE SA | 19,822,436 | $47.18M | 1.2% | — | — | SHS | H00263105 |
| TYRA | TYRA BIOSCIENCES INC | 1,476,196 | $47.15M | 1.2% | — | — | COM | 90240B106 |
| STRO | SUTRO BIOPHARMA INC | 1,251,788 | $41.56M | 1.1% | — | — | COM SHS | 869367201 |
| IMCR | IMMUNOCORE HLDGS PLC | 1,294,463 | $41.1M | 1.1% | — | — | ADS | 45258D105 |
| AVTX | AVALO THERAPEUTICS INC | 2,075,545 | $38.36M | 1.0% | — | — | COM NEW | 05338F306 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 2,879,289 | $38.29M | 1.0% | — | — | COM | 35104E100 |
| QTTB | Q32 BIO INC | 2,350,000 | $29.94M | 0.8% | — | — | COM | 746964105 |
| AVR | ANTERIS TECHNOLOGIES GLOBAL | 3,000,000 | $29.55M | 0.8% | — | — | COM | 03675P102 |
| FHTX | FOGHORN THERAPEUTICS INC | 5,842,000 | $28.51M | 0.7% | — | — | COM | 344174107 |
| ABSI | ABSCI CORPORATION | 2,361,674 | $27.37M | 0.7% | — | — | COM | 00091E109 |
| ELDN | ELEDON PHARMACEUTICALS INC | 6,293,282 | $24.8M | 0.6% | — | — | COM | 28617K101 |
| IVVD | INVIVYD INC | 28,165,000 | $24.57M | 0.6% | — | — | COM | 00534A102 |
| SGMT | SAGIMET BIOSCIENCES INC | 2,500,000 | $19.32M | 0.5% | — | — | COM SER A | 786700104 |
| OKUR | ONKURE THERAPEUTICS INC | 3,235,778 | $14.76M | 0.4% | — | — | COM CL A | 68277Q105 |
| IMUX | IMMUNIC INC | 765,295 | $11.76M | 0.3% | — | — | COM NEW | 4525EP200 |
| XFOR | X4 PHARMACEUTICALS INC | 2,233,742 | $10.43M | 0.3% | — | — | COM NEW | 98420X202 |
| IMA | IMAGENEBIO INC | 1,110,002 | $6.549M | 0.2% | — | — | COM | 45175G207 |
| TCRX | TSCAN THERAPEUTICS INC | 5,564,290 | $5.454M | 0.1% | — | — | COM | 89854M101 |
| RACC | RESEARCH ALLIANCE CORP III | 500,000 | $5.35M | 0.1% | — | — | ORD SHS CL A | G75226103 |
| MOLN | MOLECULAR PARTNERS AG | 1,353,968 | $5.145M | 0.1% | — | — | ADS | 60853G106 |
| TENX | TENAX THERAPEUTICS INC | 339,549 | $4.94M | 0.1% | — | — | COM NEW | 88032L605 |
| ENTX | ENTERA BIO LTD | 2,425,000 | $4.292M | 0.1% | — | — | SHS | M40527109 |
| IVA | INVENTIVA SA | 686,040 | $2.593M | 0.1% | — | — | ADS | 46124U107 |
| ENGNW | ENGENE THERAPEUTICS | 945,402 | $274K | 0.0% | — | — | *W EXP 10/31/202 | 29286X119 |